Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer

  1. Boyle, F.M.
  2. Smith, I.E.
  3. O'Shaughnessy, J.
  4. Ejlertsen, B.
  5. Buzdar, A.U.
  6. Fumoleau, P.
  7. Gradishar, W.
  8. Martin, M.
  9. Moy, B.
  10. Piccart-Gebhart, M.
  11. Pritchard, K.I.
  12. Lindquist, D.
  13. Amonkar, M.
  14. Huang, Y.
  15. Rappold, E.
  16. Williams, L.S.
  17. Wang-Silvanto, J.
  18. Kaneko, T.
  19. Finkelstein, D.M.
  20. Goss, P.E.
Aldizkaria:
European Journal of Cancer

ISSN: 1879-0852 0959-8049

Argitalpen urtea: 2015

Alea: 51

Zenbakia: 6

Orrialdeak: 685-696

Mota: Biltzar ekarpena

DOI: 10.1016/J.EJCA.2015.02.005 GOOGLE SCHOLAR